Saba capital management sells $179,718 in Abrdn life sciences stock

Published 15/04/2025, 15:24
Saba capital management sells $179,718 in Abrdn life sciences stock

Saba Capital Management, L.P., a significant shareholder in abrdn Life Sciences Investors (NYSE:HQL), recently sold 15,400 shares of common stock. The company, currently valued at $333.37 million, offers an impressive 15.91% dividend yield and has shown strong recent momentum with an 8.74% return over the past week. The transaction, executed on April 14, 2025, was completed at a price of $11.67 per share, resulting in a total sale value of approximately $179,718. Following this sale, Saba Capital Management retains ownership of 3,078,916 shares in the company. The transaction was disclosed in a recent SEC filing, underscoring the ongoing portfolio adjustments by the investment firm. InvestingPro analysis reveals several more key insights about HQL’s financial health and market position, with 6 additional ProTips available to subscribers.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.